Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

Presentation TCT 2024

TCT 705: Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample

Presenter: Olayiwola Bolaji

October 30, 2024

Presentation TCT 2024

TCT 697: Temporal Trends in Mortality in Patients of Atrial Fibrillation and Peripheral Artery Disease Over Past 2 Decades in the US Population

Presenter: Abdul Wali Khan

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

Shelley Wood

October 01, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

Shelley Wood

July 31, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News ISC 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

Todd Neale

February 08, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

Advertisement

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

TCT 705: Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample

TCT 697: Temporal Trends in Mortality in Patients of Atrial Fibrillation and Peripheral Artery Disease Over Past 2 Decades in the US Population

What’s Going to Be Big at TCT 2024?

TCTMD’s Top 10 Most Popular Stories for September 2024

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

September 2024 Dispatch for the CV Team

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

August 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for July 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

June 2024 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for April 2024

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content